ATYR
Atyr Pharma, Inc.
Clinical-stage biotherapeutics company focused on tRNA synthetase biology
CUSIP: 002120103HealthcareUS1 holder
Total Value
$1.18M
Total Shares
3.21M
Net Share Change
0
Activity
No changes
Investor
Value
Shares
Weight
Change
Viking Global Investors
$1.18M3.21M sharesUnchanged